Global Tumor Targeted Drug Detection Kit Market Growth 2025-2031

The global Tumor Targeted Drug Detection Kit market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

This kit is an in vitro diagnostic reagent based on second-generation sequencing technology. Detection of common driver gene mutations in non-small cell lung cancer (EGFR, ALK, ROS1, BRAF, RET, ERBB2, NTRK, KRAS, etc.) and immunotherapy positive/negative/hyper-progression related genes. The types of mutations detected include point mutations, Insertions, deletions, rearrangements, fusions. The applicable sample type is paraffin-embedded tissue sample (FFPE).

United States market for Tumor Targeted Drug Detection Kit is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Tumor Targeted Drug Detection Kit is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Tumor Targeted Drug Detection Kit is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Tumor Targeted Drug Detection Kit players cover BGI, Quest Diagnostics, Gene By Gene（myDNA Inc.）, DNA Diagnostics Center, Invitae, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Tumor Targeted Drug Detection Kit Industry Forecast” looks at past sales and reviews total world Tumor Targeted Drug Detection Kit sales in 2024, providing a comprehensive analysis by region and market sector of projected Tumor Targeted Drug Detection Kit sales for 2025 through 2031. With Tumor Targeted Drug Detection Kit sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tumor Targeted Drug Detection Kit industry.

This Insight Report provides a comprehensive analysis of the global Tumor Targeted Drug Detection Kit landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tumor Targeted Drug Detection Kit portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tumor Targeted Drug Detection Kit market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tumor Targeted Drug Detection Kit and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tumor Targeted Drug Detection Kit.

This report presents a comprehensive overview, market shares, and growth opportunities of Tumor Targeted Drug Detection Kit market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Single Gene Testing
Multigene Testing

Segmentation by Application:
Online Sales
Offline Sales

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
BGI
Quest Diagnostics
Gene By Gene（myDNA Inc.）
DNA Diagnostics Center
Invitae
Ambry Genetics
Living DNA
EasyDNA
Pathway Genomics
Centrillion Technology
Color Genomics
Anglia DNA Services
African Ancestry
Canadian DNA Services
DNA Family Check
Alpha Biolaboratories
Test Me DNA
23 Mofang
Genetic Health

Key Questions Addressed in this Report

What is the 10-year outlook for the global Tumor Targeted Drug Detection Kit market?

What factors are driving Tumor Targeted Drug Detection Kit market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Tumor Targeted Drug Detection Kit market opportunities vary by end market size?

How does Tumor Targeted Drug Detection Kit break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.